Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease

Citation
Mn. Starkman et al., Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease, BIOL PSYCHI, 46(12), 1999, pp. 1595-1602
Citations number
27
Categorie Soggetti
Neurosciences & Behavoir
Journal title
BIOLOGICAL PSYCHIATRY
ISSN journal
00063223 → ACNP
Volume
46
Issue
12
Year of publication
1999
Pages
1595 - 1602
Database
ISI
SICI code
0006-3223(199912)46:12<1595:DICRHH>2.0.ZU;2-V
Abstract
Background: Decreased hippocampal volume is observed in patients with Cushi ng's syndrome and other conditions associated with elevated cortisol levels , stress, or both. Reversibility of hippocampal neuronal atrophy resulting from stress occurs in animals. Our study investigated the potential for rev ersibility of human hippocampal atrophy. Methods: The study included 22 patients with Gushing's disease. Magnetic re sonance brain imaging was performed prior to transsphenoidal microadenomect omy and again after treatment. Results: Following treatment, hippocampal formation volume (HFV) increased by up to 10%. The mean percent change (3.2 +/- 2.5) was significantly great er (p < .04) than that of the comparison structure, caudate head volume (1. 5 +/- 3.4). Increase in HFV was significantly associated with magnitude of deer-ease in urinary free cortisol (r = -.61, p < .01). This relationship s trengthened after adjustments for age, duration of disease, and months elap sed since surgery (r = -.70, p < .001). There was no significant correlatio n between caudate head volume change and magnitude of cortisol decrease. Conclusions: Changes in human HFV associated with sustained hypercortisolem ia are reversible, at least in part, once cortisol levels decrease. While m any brain regions are likely affected by hypercortisolemia, the human hippo campus exhibits increased sensitivity to cortisol, affecting both volume lo ss and recovery. Biol Psychiatry 1999;46:1595-1602 (C) 1999 Society of Biol ogical Psychiatry.